Compare OGI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGI | CBUS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 69.9M |
| IPO Year | N/A | 2017 |
| Metric | OGI | CBUS |
|---|---|---|
| Price | $1.73 | $1.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.8M | 188.7K |
| Earning Date | 02-10-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $186,075,713.00 | $3,794,000.00 |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $6.02 | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $1.09 |
| 52 Week High | $2.24 | $3.40 |
| Indicator | OGI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 64.89 |
| Support Level | $1.67 | $1.59 |
| Resistance Level | $1.86 | $1.80 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 31.33 | 89.70 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.